tiprankstipranks
Ultragenyx Pharmaceutical (GB:0LIF)
LSE:0LIF

Ultragenyx Pharmaceutical (0LIF) Stock Investors

0 Followers
Based on 727,786 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold GB:0LIF
On average, investors allocate 4.09% of their portfolios to GB:0LIF
The average holding size of this company in investors' portfolios.

Investor Sentiment

Currently, no data available
Please return soon. This page is being updated.
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding 0LIF

0.4%
Last 7
Days
5.0%
Last 30
Days
Percentages indicate the change in the number of portfolios holding GB:0LIF, out of 727,786 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

0LIF Investor Activity

No data currently available
Based on the activity of 13,676 investors who made their portfolios public
The table shows changes in 0LIF in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

0LIF Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Trade Desk
4.77%
-1.23%
-2.24%
42.23B
Technology
ServiceNow
4.03%
+0.08%
-0.45%
157.59B
Technology
DraftKings
7.11%
-0.77%
-2.93%
38.32B
Consumer Cyclical
Marvell
4.88%
+2.15%
+7.30%
60.76B
Technology
Block
4.54%
-1.92%
-6.99%
47.40B
Technology
Merck & Company
4.12%
+0.13%
-0.70%
318.45B
Healthcare
Mercadolibre
5.30%
-0.82%
-2.97%
73.21B
Consumer Cyclical
Micron
5.82%
+1.77%
+26.21%
135.67B
Technology
Salesforce
4.97%
+0.98%
-1.77%
285.49B
Technology
Mastercard
4.76%
+0.08%
-2.22%
434.15B
Financial
Based on the activity of 727,786 active portfolios
Open your Smart Portfolio

0LIF Investor Analysis

GB:0LIF investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
8.6%
of GB:0LIF holders
are under 35
Average Segment Performance
Average P/E Ratio57.26
Beta6.62
Dividend Yield5.85%
GB:0LIF investors between 35–55

Between 35–55

5.7%
Last 30 days
Holdings Change
52.7%
of GB:0LIF holders
are between 35–55
Average Segment Performance
Average P/E Ratio62.56
Beta11.45
Dividend Yield8.22%
GB:0LIF investors over 55

Over 55

5.3%
Last 30 days
Holdings Change
38.7%
of GB:0LIF holders
are over 55
Average Segment Performance
Average P/E Ratio54.63
Beta4.16
Dividend Yield22.09%
Overview of age group and performance of GB:0LIF stock investors
See who invests in 0LIF according to age group and performance.

FAQ

How many retail Investors hold GB:0LIF?
<0.1% of TipRanks' retail investors hold GB:0LIF in their portfolios.
    What is GB:0LIF Investor Sentiment?
    GB:0LIF’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of GB:0LIF in the last 7 days?
      ▼ 0.4% of TipRanks' retail investors changed their holding of GB:0LIF in the last 7 days.
        What percentage of retail investors changed their holding of GB:0LIF in the last 30 days?
        ▼ 5.0% of TipRanks' retail investors changed their holding of GB:0LIF in the last 30 days.
          What is the average age of retail investors who hold GB:0LIF?
          The average age of GB:0LIF Holders is between 35–55.
            What other stocks have GB:0LIF investors also bought?
            GB:0LIF Investors also bought TTD, NOW, DKNG, MRVL, SQ, MRK, MELI, MU, CRM, MA.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              AGENAgenus
              ATECAlphatec Holdings
              CORCencora
              BAXBaxter International
              NOTVInotiv
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis